Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
boston blog main
boston top stories
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
4
×
national
new york blog main
new york top stories
san diego blog main
san diego top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
crispr
detroit blog main
detroit top stories
gilead sciences
indiana blog main
indiana top stories
intellia therapeutics
raleigh-durham blog main
raleigh-durham top stories
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alector
alirocumab
alkermes
allergan
amgen
avrobio
baricitinib
bcma
biotech
What
known
4
×
new
4
×
crispr
drug
medicine
approved
bio
biopharma
cancer
cas
cells
cholesterol
congress
congressional
data
defect
disease
drive
drugs
edited
editing
executives
expensive
faces
fatty
fears
feud
financial
flag
foe
gene
genetic
group
guardian
healthcare
hint
horizon
human
inhibitors
intercept
Language
unset
Current search:
known
×
photo
×
new
×
" san francisco top stories "
×
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
6 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells